242 related articles for article (PubMed ID: 27234767)
1. Prognosis of Kidney Transplant Recipients With Pretransplantation Malignancy: A Nationwide Population-Based Cohort Study in Taiwan.
Chiu HF; Chung MC; Chung CJ; Yu TM; Shu KH; Wu MJ
Transplant Proc; 2016 Apr; 48(3):918-20. PubMed ID: 27234767
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of post-transplant malignancy and mortality in transplant tourists: a nationwide population-based cohort study in Taiwan.
Chung MC; Wu MJ; Chang CH; Muo CH; Yu TM; Ho HC; Shu KH; Chung CJ
Medicine (Baltimore); 2014 Dec; 93(29):e344. PubMed ID: 25546686
[TBL] [Abstract][Full Text] [Related]
3. De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan.
Yeh CC; Khan A; Muo CH; Yang HR; Li PC; Chang CH; Chen TL; Jeng LB; Liao CC
Exp Clin Transplant; 2020 Apr; 18(2):224-233. PubMed ID: 32133940
[TBL] [Abstract][Full Text] [Related]
4. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
[TBL] [Abstract][Full Text] [Related]
5. Malignancy in Renal Transplant Recipients Exposed to Cyclophosphamide Prior to Transplantation for the Treatment of Native Glomerular Disease.
Jorgenson MR; Descourouez JL; Singh T; Astor BC; Panzer SE
Pharmacotherapy; 2018 Jan; 38(1):51-57. PubMed ID: 29136299
[TBL] [Abstract][Full Text] [Related]
6. Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.
Dahle DO; Grotmol T; Leivestad T; Hartmann A; Midtvedt K; Reisæter AV; Mjøen G; Pihlstrøm HK; Næss H; Holdaas H
Transplantation; 2017 Oct; 101(10):2599-2605. PubMed ID: 28207636
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Specific and All-Cause Mortality in Kidney Transplant Recipients With and Without Previous Cancer.
Viecelli AK; Lim WH; Macaskill P; Chapman JR; Craig JC; Clayton P; Cohney S; Carroll R; Wong G
Transplantation; 2015 Dec; 99(12):2586-92. PubMed ID: 26102612
[TBL] [Abstract][Full Text] [Related]
8. Sex difference for urologic malignancy risk in uremic patients after kidney transplantation: a population-based study.
Hwang JC; Jiang MY; Lu YH; Weng SF
Transplantation; 2015 Apr; 99(4):818-22. PubMed ID: 25208323
[TBL] [Abstract][Full Text] [Related]
9. Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.
Lee KF; Tsai YT; Lin CY; Hsieh CB; Wu ST; Ke HY; Lin YC; Lin FY; Lee WH; Tsai CS
PLoS One; 2016; 11(5):e0155602. PubMed ID: 27196400
[TBL] [Abstract][Full Text] [Related]
10. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
[TBL] [Abstract][Full Text] [Related]
11. Impact of pulmonary and extrapulmonary tuberculosis infection in kidney transplantation: a nationwide population-based study in Taiwan.
Ou SM; Liu CJ; Teng CJ; Lin YT; Chang YS; Chiang SC; Tzeng CH; Chen TJ
Transpl Infect Dis; 2012 Oct; 14(5):502-9. PubMed ID: 22571347
[TBL] [Abstract][Full Text] [Related]
12. Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history.
Brattström C; Granath F; Edgren G; Smedby KE; Wilczek HE
Transplantation; 2013 Aug; 96(3):297-305. PubMed ID: 23759880
[TBL] [Abstract][Full Text] [Related]
13. Malignancies after renal transplantation in southern Taiwan: experience in one centre.
Feng WW; Wang TN; Chen HC; Ho JC; Ko YC
BJU Int; 2007 Apr; 99(4):825-9. PubMed ID: 17155978
[TBL] [Abstract][Full Text] [Related]
14. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
[TBL] [Abstract][Full Text] [Related]
15. Malignancy following renal transplantation.
Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
[TBL] [Abstract][Full Text] [Related]
16. Risk and outcome of pyelonephritis among renal transplant recipients.
Graversen ME; Dalgaard LS; Jensen-Fangel S; Jespersen B; Østergaard L; Søgaard OS
BMC Infect Dis; 2016 Jun; 16():264. PubMed ID: 27287058
[TBL] [Abstract][Full Text] [Related]
17. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
[TBL] [Abstract][Full Text] [Related]
18. High cumulative incidence of urinary tract transitional cell carcinoma after kidney transplantation in Taiwan.
Wu MJ; Lian JD; Yang CR; Cheng CH; Chen CH; Lee WC; Shu KH; Tang MJ
Am J Kidney Dis; 2004 Jun; 43(6):1091-7. PubMed ID: 15168390
[TBL] [Abstract][Full Text] [Related]
19. Patient survival after renal transplantation; more than 25 years follow-up.
Arend SM; Mallat MJ; Westendorp RJ; van der Woude FJ; van Es LA
Nephrol Dial Transplant; 1997 Aug; 12(8):1672-9. PubMed ID: 9269647
[TBL] [Abstract][Full Text] [Related]
20. Should patients older than 65 years be offered a second kidney transplant?
Heldal K; Hartmann A; Lønning K; Leivestad T; Reisæter AV; Line PD; Holdaas H; Midtvedt K
BMC Nephrol; 2017 Jan; 18(1):13. PubMed ID: 28077080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
